Please click
 User   Pwd      Remember
Article Search: 
BiotechEast
· Home
· About us
· Services
· FAQ
· Contact us
Info Resources
· Companies
· Institutes
· Science parks
· Life science news
· Company spotlight
· Taiwan bio report
· Feature articles
· Asia-Pacific events
· Investment corner
· Technology transfer
· Int'l biotech links
· Info resources search
· Job listings
· Log out
Partners



Previous  8 9 10 11 12 13 14 15 16 17 ... Total pages:260  Next 

Life Science News

(Taiwan) World's first blood test for Alzheimer's


(China Post, Taiwan)

3 April, 2015
National Taiwan Normal University (NTNU) Institute of Electro-optical Science and Technology researchers and National Taiwan University Hospital's (NTUH) Neurology Department announced the creation of the world's first blood test for Alzheimer's disease yesterday at an academic symposium.
More...




Life Science News

(Taiwan) Ergomed opens first Asia office


(Insidermedia.com)

24 March, 2015
Guildford, UK-headquartered drug development services company Ergomed has opened its first office in Asia. The company said the new Taiwan base strengthens its clinical research and consultancy presence in the continent, and is a "key element" of the company's growth plan set out at the initial public offering (IPO).
More...




Life Science News

(Taiwan) TaiGen and Cellex to collaborate on Burixafor study


(China Post, Taiwan)

19 March, 2015
Taiwan's TaiGen Biotechnology Company and German firm Cellex GmbH announced a collaborative agreement in clinical trial usage of Burixafor, yesterday. The Carl Gustav Carus University Hospital will also participate in the study titled “Burixafor in allogeneic poor mobilizers,” which looks at the effect of a single dose of Burixafor. The test, a Phase 2 open label study, will target up to 37 healthy patients with poor stem cell mobilization.
More...




Life Science News

(Taiwan) TWi Pharmaceuticals becomes first from Taiwan to sell generics in the US under own label


(BiotechEast staff)

17 March, 2015
TWi Pharmaceuticals, Inc. (4180.TW) announced yesterday that its US subsidiary, TWi Pharmaceuticals USA, had shipped the first generic product under its own label on March 16, 2015, making it the first Taiwanese pharmaceutical company to directly sell generic pharmaceutical products under its own label in the US.




Life Science News

(Taiwan) Taiwanese funds invest in genetic medicine initiative


(WantChinaTimes.com)

15 February, 2015
Taiwan's venture capital companies are eyeing investing in genetic testing to diagnose diseases, reports our Chinese-language sister paper Commercial Times.
More...




Life Science News

(Taiwan) ASLAN Pharmaceuticals appoints Dr Bertil Lindmark as Chief Scientific Officer


(BiotechEast staff)

28 January, 2015
ASLAN Pharmaceuticals Pte Ltd, an oncology-focused biotechnology company, announced last week the appointment of Dr Bertil Lindmark as Chief Scientific Officer.




Life Science News

(Taiwan) GNT receives EU food additive certification for its gold flake product


(BiotechEast staff)

29 January, 2015
Taipei, Taiwan-headquartered biotech-nanotech product development company Gold Nanotech Inc. (GNT) announced this week that it had received notification of compliance to the European Union's food additive regulation E175 for its edible gold flake product




Life Science News

(Taiwan) Chang Gung bone bank helps save medical expenses: physician


(Focus Taiwan)

21 December, 2014
Chang Gung Memorial Hospital is proud of its achievements in running a bone bank, including helping save Taiwan NT$6 billion (US$190 million) in medical expenditures since it was set up in 1984.
More...




Life Science News

(Taiwan) Cancer communication cracked


(Taipei Times)

15 December, 2014
National Yang-Ming University and Taipei Veterans General Hospital recently unveiled a breakthrough finding that explains how cancer cells promote the recruitment of tumor-associated macrophages to remodel a tumor’s microenvironment to aid growth.
More...




Life Science News

(Taiwan) Price of MedeonBio stock triples after market debut


(Taipei Times)

15 December, 2014
Shares of Medeon Biodesign Inc (益安生醫), which makes medical devices for minimally invasive surgeries, tripled in value from Tuesday through Friday after its debut on the Emerging Stock Market, as investors have high hopes for its management team.
More...




Sponsors

Events



Taiwan Life Sciences Bulletin

Enter email address to receive free e-newsletter


Sample

Disclaimer and Privacy Policy